Skip to main content

$0.315 0.010 (3.28%)

High

$0.32

Low

$0.30

Trades

243

Turnover

$627,825

Volume

2,012,212
30 June 2023 at 4:10pm
Register to track IMM and receive email alerts.

Positive ORR in 1st line NSCLC from ph 2 TACTI-002 trial

StockBot

416,823 posts

IMM released this announcement to the ASX on 6 June 2022, 8:20. The announcement is marked as price sensitive, and is 5 page(s) in length and 400.36kb in size.

You can view all announcements from IMM and see how they appear on a price chart on the announcements page.

At the date of this announcement, IMM was 1.216% short sold according to ASIC data. It was ranked the 183rd most shorted stock on the ASX. It is now ranked as the 138th most shorted stock on the ASX with 1.859% of total shares short sold as of the latest reported data (19 June 2025).

Other Recent Announcements from IMM
Application for quotation of securities - IMM 29 June 2023, 10:09
US patent granted for Efti with PD-1 pathway inhibitor 27 June 2023, 14:37
Immutep completes underwritten retail entitlement offer 27 June 2023, 8:16
Positive ORR in 1st line NSCLC from ph 2 TACTI-002 trial 6 June 2022, 8:20
Immutep webcast for TACTI-002 data presented at ASCO 2022 2 June 2022, 8:17
Immutep announces publication of ASCO 2022 abstracts 27 May 2022, 7:34
Immutep Corporate Presentation 24 May 2022, 17:28
You must login or register to post a comment.

You must be logged in to post a reply.

Register to track IMM and receive email alerts.